SCHEMBL15412031

SCHEMBL15412031

CC(N)c1nc2ccn(C)c2cc1N1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 5/20 0.43
FAAH O00519 1/20 0.43
NCF1 P14598 2/20 0.40
PIK3CA P42336 5/20 0.37
PIK3CB P42338 4/20 0.37
PIK3CG P48736 3/20 0.37
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LGMN Q99538 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15410910 1.00 PIK3CD (0.43) PIK3CDFAAHNCF1PIK3CAPIK3CB
SCHEMBL15411077 1.00 PIK3CD (0.43) PIK3CDFAAHNCF1PIK3CAPIK3CB
SCHEMBL15412007 0.82 PIK3CD (0.38) PIK3CDFAAH
SCHEMBL15410685 0.82 PIK3CD (0.42) PIK3CD
SCHEMBL16874994 0.81 PIK3CD (0.43) PIK3CDFAAHNCF1PIK3CAPIK3CB
SCHEMBL16874996 0.81 PIK3CD (0.43) PIK3CDFAAHNCF1PIK3CAPIK3CB
SCHEMBL15411116 0.81 PIK3CD (0.40) PIK3CDPIK3CB
SCHEMBL15411665 0.80 PIK3CD (0.39) PIK3CDFAAH
SCHEMBL16875056 0.79 PIK3CD (0.39) PIK3CDSMN1; SMN2
SCHEMBL15411797 0.78 PIK3CD (0.38) PIK3CDFAAHTSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140343033-A1 AZAINDOLE DERIVATIVES Takeda Califomia, Inc. (US) 2014-11-20 US disclosed
US-20140343033-A1 AZAINDOLE DERIVATIVES Takeda Califomia, Inc. (US) 2014-11-20 US disclosed
US-20140343033-A1 AZAINDOLE DERIVATIVES Takeda Califomia, Inc. (US) 2014-11-20 US disclosed
US-8835420-B2 Azaindole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-09-16 US disclosed
US-8835420-B2 Azaindole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-09-16 US disclosed
US-8835420-B2 Azaindole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-09-16 US disclosed
US-20140018344-A1 AZAINDOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-16 US disclosed
US-20140018344-A1 AZAINDOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-16 US disclosed
US-20140018344-A1 AZAINDOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-16 US disclosed
WO-2014011568-A1 AZAINDOLE DERIVATIVES WHICH ACT AS PI3K INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343033-A1 AZAINDOLE DERIVATIVES PIK3R5, PIK3R1, PIK3R2 PIK3CD 6/4885FAAH 4793/4885NCF1 2091/4885
US-20140018344-A1 AZAINDOLE DERIVATIVES PIK3R5, PIK3R1, PIK3R2 PIK3CD 6/4885FAAH 4793/4885NCF1 2091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.